CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex

Genes and Development

Volumn 14, Issue 9, 2000, Pages 1156-1166

  Masternak, Krzysztof ^a   Muhlethaler Mottet, Annick ^a   Villard, Jean ^a   Zufferey, Madeleine ^a   Steimle, Viktor ^b   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

CIITA; Coactivator; Enhanceosome; Gene regulation; MHC class II; Transcription

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION;

B-LYMPHOCYTES; CELL LINE; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034194473     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Abdulkadir, S.A., S. Krishna, D. Thanos, T. Maniatis, J.L. Strominger, and S.J. Ono. 1995. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J. Exp. Med. 182: 487-500.
2. Accolla, R.S. 1983. Human B cell variants immunoselected against a single Ia antigen subset have lost expression in several Ia antigen subsets. J. Exp. Med. 157: 1053-1058.
3. Benoist, C. and D. Mathis. 1990. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8: 681-715.
4. Bontron, S., V. Steimle, C. Ucla, and B. Mach. 1997a. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99: 541-546.
5. Bontron, S., C. Ucla, B. Mach, and V. Steimle. 1997b. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol. Cell. Biol. 17: 4249-4258.
6. Boss, J.M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9: 107-113.
7. Brown, J.A., E.M. Rogers, and J.M. Boss. 1998. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26: 4128-4136.
8. Carey, M. 1998. The enhanceosome and transcriptional synergy. Cell 92: 5-8.
9. Chang, C.H., S. Guerder, S.C. Hong, W. van Ewijk, and R.A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178.
10. Chin, K.C., G.G. Li, and J.P. Ting. 1997. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. 94: 2501-2506.
11. Clausen, B.E., J.M. Waldburger, F. Schwenk, E. Barras, B. Mach, K. Rajewsky, I. Forster, and W. Reith. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8: 143-155.
12. Cressman, D.E., K.C. Chin, D.J. Taxman, and J.P. Ting. 1999. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 10: 163-171.
13. David-Watine, B., A. Israel, and P. Kourilsky. 1990. The regulation and expression of MHC class I genes. Immunol. Today 11: 286-292.
14. de Preval, C., B. Lisowska-Grospierre, M. Loche, C. Griscelli, and B. Mach. 1985. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318: 291-293.
15. Durand, B., M. Kobr, W. Reith, and B. Mach. 1994. Functional complementation of MHC class II regulatory mutants by the purified X box binding protein RFX. Mol. Cell. Biol. 14: 6839-6847.
16. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16: 1045-1055.
17. Fimia, G.M., D. De Cesare, and P. Sassone-Corsi. 1999. CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature 398: 165-169.
18. Fontes, J.D., N. Jabrane-Ferrat, C.R. Toth, and B.M. Peterlin. 1996. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. Med. 183: 2517-2521.
19. Fontes, J.D., S. Kanazawa, D. Jean, and B.M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompat-ibility complex class II genes. Mol. Cell. Biol. 19: 941-947.
20. Fuerst, T.R., E.G. Niles, F.W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. 83: 8122-8126.
21. Ghosh, N., J.F. Piskurich, G. Wright, K. Hassani, J.P. Ting, and K.L. Wright. 1999. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes. J. Biol. Chem. 274: 32342-32350.
22. Glimcher, L.H. and C.J. Kara. 1992. Sequences and factors: A guide to MHC class-II transcription. Annu. Rev. Immunol. 10: 13-49.
23. Gobin, S.J., A. Peijnenburg, V. Keijsers, and P.J. van den Elsen. 1997. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA. Immunity 6: 601-611.
24. Gourley, T., S. Roys, N.W. Lukacs, S.L. Kunkel, R.A. Flavell, and C.H. Chang. 1999. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10: 377-386.
25. Gstaiger, M., L. Knoepfel, O. Georgiev, W. Schaffner, and C.M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature 373: 360-362.
26. Itoh-Lindstrom, Y., J.F. Piskurich, N.J. Felix, Y. Wang, W.J. Brickey, J.L. Platt, B.H. Koller, and J.P. Ting. 1999. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 163: 2425-2431.
27. Kara, C.J. and L.H. Glimcher. 1991. In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome. Science 252: 709-712.
28. _. 1993. Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics 37: 227-230.
29. Kobr, M., W. Reith, C. Herrero Sanchez, and B. Mach. 1990. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol. Cell. Biol. 10: 965-971.
30. Kretsovali, A., T. Agalioti, C. Spilianakis, E. Tzortzakaki, M. Merika, and J. Papamatheakis. 1998. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell Biol. 18: 6777-6783.
31. Louis-Plence, P., C.S. Moreno, and J.M. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159: 3899-3909.
32. Luo, Y. and R.G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15: 4115-4124.
33. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immunol. 14: 301-331.
34. Mahanta, S.K., T. Scholl, F.C. Yang, and J.L. Strominger. 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. 94: 6324-6329.
35. Maity, S.N. and B. De Crombrugghe. 1998. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem. Sci. 23: 174-178.
36. Mantovani, R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239: 15-27.
37. Martin, B.K., K.C. Chin, J.C. Olsen, C.A. Skinner, A. Dey, K. Ozato, and J.P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6: 591-600.
38. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J.C. Sanchez, D.F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20: 273-277.
39. Merika, M., A.J. Williams, G. Chen, T. Collins, and D. Thanos. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1: 277-287.
40. Moreno, C.S., G.W. Beresford, P. Louis-Plence, A.C. Morris, and J.M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10: 143-151.
41. Muhlethaler-Mottet, A., L.A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16: 2851-2860.
42. Nagarajan, U.M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J.M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10: 153-162.
43. Orlando, V., H. Strutt, and R. Paro. 1997. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11: 205-214.
44. Otten, L.A., V. Steimle, S. Bontron, and B. Mach. 1998. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28: 473-478.
45. Piskurich, J.F., M.W. Linhoff, Y. Wang, and J.P. Ting. 1999. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol. Cell. Biol. 19: 431-440.
46. Puigserver, P., Z. Wu, C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
47. Reith, W., S. Satola, C. Herrero Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M.R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53: 897-906.
48. Reith, W., M. Kobr, P. Emery, B. Durand, C.A. Siegrist, and B. Mach. 1994a. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269: 20020-20025.
49. Reith, W., C.A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994b. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. 91: 554-558.
50. Riley, J.L., S.D. Westerheide, J.A. Price, J.A. Brown, and J.M. Boss. 1995. Activation of class II MHC genes requires both the X box and the class II transactivator (CIITA). Immunity 2: 533-543.
51. Roeder, R.G. 1998. Role of general and gene-specific cofactors in the regulation of eukaryotic transcription. Cold Spring Harb. Symp. Quant. Biol. 63: 201-218.
52. Scholl, T., S.K. Mahanta, and J.L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. 94: 6330-6334.
53. Sherman, P.A., P.V. Basta, A. Heguy, M.K. Wloch, R.G. Roeder, and J.P. Ting. 1989. The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DR alpha gene promoter. Proc. Natl. Acad. Sci. 86: 6739-6743.
54. Silacci, P., A. Mottet, V. Steimle, W. Reith, and B. Mach. 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180: 1329-1336.
55. Singer, D.S. and J.E. Maguire. 1990. Regulation of the expression of class I MHC genes. Crit. Rev. Immunol. 10: 235-257.
56. Steimle, V., L.A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency. Cell 75: 135-146.
57. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by Interferon-gamma mediated by the transactivator gene CIITA. Science 265: 106-109.
58. Steimle, V., B. Durand, E. Barras, M. Zufferey, M.R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (Bare Lymphocyte Syndrome). Genes & Dev. 9: 1021-1032.
59. Strubin, M., J.W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with Octamer-binding proteins. Cell 80: 497-506.
60. Thanos, D. and T. Maniatis. 1995. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.
61. Ting, J.P. and A.S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Imnmnol. 5: 8-16.
62. Tsang, S.Y., M. Nakanishi, and B.M. Peterlin. 1990. Mutational analysis of the DRA promoter: Cis-acting sequences and trans-acting factors. Mol. Cell. Biol. 10: 711-719.
63. van den Elsen, P.J., A. Peijnenburg, M.C. van Eggermond, and S.J. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 19: 308-312.
64. Vilen, B.J., J.P. Cogswell, and J.P. Ting. 1991. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol. Cell. Biol. 11: 2406-2415.
65. Vilen, B.J., J.F. Penta, and J.P.-Y. Ting. 1992. Structural constraints within a trimeric transcriptional regulatory region: Constitutive and Interferon-g inducible expression of the HLA-DRA gene. J. Biol. Chem. 267: 23728-23734.
66. Villard, J., A. Muhlethaler-Mottet, S. Bontron, B. Mach, and W. Reith. 1999. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes. Int. Immunol. 11: 461-469.
67. Villard, J., M. Peretti, K. Masternak, E. Barras, G. Caretti, R. Mantovani, and W. Reith. 2000. A functionally essential domain of RFX5 mediates activation of MHC class II promoters by promoting cooperative binding between RFX and NF-Y. Mol. Cell. Biol. (In press).
68. Williams, G.S., M. Malin, D. Vremec, C.H. Chang, R. Boyd, C. Benoist, and D. Mathis. 1998. Mice lacking the transcription factor CIITA-a second look. Int. Immunol. 10: 1957-1967.
69. Wright, K.L., B.J. Vilen, Y. Itoh Lindstrom, T.L. Moore, G. Li, M. Criscitiello, P. Cogswell, J.B. Clarke, and J.P. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13: 4042-4053.
70. Wright, K.L., K.C. Chin, M. Linhoff, C. Skinner, J.A. Brown, J.M. Boss, G.R. Stark, and J.P. Ting. 1998. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. 95: 6267-6272.
71. Wu, W.H. and M. Hampsey. 1999. Common cofactors and cooperative recruitment. Curr. Biol. 9: R606-R609
72. Xu, L., C.K. Glass, and M.G. Rosenfeld. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9: 140-147.
73. Zhou, H. and L.H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2: 545-553.